Literature DB >> 526260

Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.

A M Lefer, E W Polansky, C P Bianchi, S Narayan.   

Abstract

Verapamil, at a dose of 1 mg/kg, was given intravenously to anesthetized cats one hour after coronary artery occlusion. Verapamil significantly reduced mean arterial blood pressure, but produced an increase in heart rate, partially offsetting the reduction in myocardial oxygen demand resulting from the reduction in pressure. Verapamil failed to prevent the elevations in the S-T segment of the electrocardiogram observed in cats subjected to myocardial ischemia (MI) and given only the vehicle for verapamil (i.e., 0.9% NaCl). Moreover, verapamil also did not prevent the accumulation of creatine phosphokinase (CPK) activity in the circulating blood after MI. Nevertheless, verapamil significantly prevented the loss in CPK and in amino-nitrogen observed in the ischemic region of the myocardium, indicating some protective effect on myocardial integrity. The major effects of verapamil on electrolyte content of ischemic myocardial tissue were a decrease in sodium and an increase in potassium. However, calcium gain by the heart was not prevented by verapamil. Verapamil, therefore, exerts a partial degree of protection of the ischemic myocardium but exerts some other effects which do not help prevent the spread of ischemic damage in the myocardium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526260     DOI: 10.1007/BF01907648

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  31 in total

1.  Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium.

Authors:  M R Bristow; R D Green
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

2.  Pancreatic hydrolases and the formation of a myocardial depressant factor in shock.

Authors:  A M Lefer; Y Barenholz
Journal:  Am J Physiol       Date:  1972-11

Review 3.  Verapamil and the myocardium.

Authors:  W G Nayler; D Krikler
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

4.  Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle.

Authors:  W G Nayler; J Szeto
Journal:  Cardiovasc Res       Date:  1972-03       Impact factor: 10.787

5.  Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat.

Authors:  J A Spath; D L Lane; A M Lefer
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

6.  Localization of glucocorticoid uptake in normal and ischemic myocardial tissue of isolated perfused cat hearts.

Authors:  M Okuda; K R Young; A M Lefer
Journal:  Circ Res       Date:  1976-11       Impact factor: 17.367

7.  Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; J E Lowe; R B Jennings
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

8.  Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.

Authors:  L M Mangiardi; R J Hariman; R G McAllister; V Bhargava; B Surawicz; R Shabetai
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

9.  Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.

Authors:  F Hagemeijer
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

10.  Lack of protection of ischemic myocardium by verapamil in conscious dogs.

Authors:  R P Karlsberg; P D Henry; S A Ahmed; B E Sobel; R Roberts
Journal:  Eur J Pharmacol       Date:  1977-04-21       Impact factor: 4.432

View more
  7 in total

Review 1.  Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium.

Authors:  J A Lee; D G Allen
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Effects of the calcium antagonist gallopamil on the increase of myocardial extracellular potassium activity during LAD occlusion in dogs.

Authors:  M Budden; M Kirchengast; K M Zhang; W Meesmann
Journal:  Basic Res Cardiol       Date:  1987 May-Jun       Impact factor: 17.165

Review 3.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells.

Authors:  F Gao; B Gong; T A Christopher; B L Lopez; A Karasawa; X L Ma
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

5.  Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.

Authors:  W Bernauer
Journal:  Klin Wochenschr       Date:  1982-01-15

6.  Evaluation of the protective effect of verapamil on reperfusion injury by 111In anticardiac myosin antibody in canine myocardial infarction.

Authors:  J K Chung; S M Lim; M C Lee; C S Koh; M Lee; J W Seo
Journal:  Ann Nucl Med       Date:  1991-09       Impact factor: 2.668

7.  Antiapoptotic mechanisms of benidipine in the ischemic/reperfused heart.

Authors:  Hui-Rong Liu; Feng Gao; Ling Tao; Wen-Li Yan; Erhe Gao; Theodore A Christopher; Bernard L Lopez; Aihua Hu; Xin L Ma
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.